Tumor mutational burden as a tissue-agnostic biomarker for cancer immunotherapy

Tumor mutational burden (TMB), the total number of somatic mutations per coding area of a tumor genome,1 has emerged as a biomarker predictive of response to immune checkpoint inhibition. Conventio...